Do cost-sharing and entry deregulation curb pharmaceutical innovation?:
Gespeichert in:
| Beteilige Person: | |
|---|---|
| Format: | Buch |
| Sprache: | Englisch |
| Veröffentlicht: |
München
CESifo
2011
|
| Schriftenreihe: | CESifo working paper
3439 : Category 1, Public finance |
| Links: | http://www.cesifo-group.de/portal/pls/portal/docs/1/1205521.PDF |
| Umfang: | 41 S. graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV037492676 | ||
| 003 | DE-604 | ||
| 005 | 20110809 | ||
| 007 | t| | ||
| 008 | 110624s2011 xx d||| |||| 00||| eng d | ||
| 035 | |a (OCoLC)745480729 | ||
| 035 | |a (DE-599)GBV660775697 | ||
| 040 | |a DE-604 |b ger | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-M382 |a DE-12 |a DE-19 |a DE-521 |a DE-188 |a DE-355 | ||
| 100 | 1 | |a Grossmann, Volker |d 1971- |e Verfasser |0 (DE-588)122499263 |4 aut | |
| 245 | 1 | 0 | |a Do cost-sharing and entry deregulation curb pharmaceutical innovation? |c Volker Grossmann |
| 264 | 1 | |a München |b CESifo |c 2011 | |
| 300 | |a 41 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a CESifo working paper |v 3439 : Category 1, Public finance | |
| 830 | 0 | |a CESifo working paper |v 3439 : Category 1, Public finance |w (DE-604)BV013978326 |9 3439 | |
| 856 | 4 | 1 | |u http://www.cesifo-group.de/portal/pls/portal/docs/1/1205521.PDF |z kostenfrei |3 Volltext |
| 912 | |a ebook | ||
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-022643951 | |
Datensatz im Suchindex
| _version_ | 1818973055457689600 |
|---|---|
| any_adam_object | |
| author | Grossmann, Volker 1971- |
| author_GND | (DE-588)122499263 |
| author_facet | Grossmann, Volker 1971- |
| author_role | aut |
| author_sort | Grossmann, Volker 1971- |
| author_variant | v g vg |
| building | Verbundindex |
| bvnumber | BV037492676 |
| collection | ebook |
| ctrlnum | (OCoLC)745480729 (DE-599)GBV660775697 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01042nam a2200289 cb4500</leader><controlfield tag="001">BV037492676</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20110809 </controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">110624s2011 xx d||| |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)745480729</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)GBV660775697</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-M382</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-521</subfield><subfield code="a">DE-188</subfield><subfield code="a">DE-355</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Grossmann, Volker</subfield><subfield code="d">1971-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)122499263</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Do cost-sharing and entry deregulation curb pharmaceutical innovation?</subfield><subfield code="c">Volker Grossmann</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">München</subfield><subfield code="b">CESifo</subfield><subfield code="c">2011</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">41 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">CESifo working paper</subfield><subfield code="v">3439 : Category 1, Public finance</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">CESifo working paper</subfield><subfield code="v">3439 : Category 1, Public finance</subfield><subfield code="w">(DE-604)BV013978326</subfield><subfield code="9">3439</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">http://www.cesifo-group.de/portal/pls/portal/docs/1/1205521.PDF</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ebook</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-022643951</subfield></datafield></record></collection> |
| id | DE-604.BV037492676 |
| illustrated | Illustrated |
| indexdate | 2024-12-20T15:18:05Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-022643951 |
| oclc_num | 745480729 |
| open_access_boolean | 1 |
| owner | DE-M382 DE-12 DE-19 DE-BY-UBM DE-521 DE-188 DE-355 DE-BY-UBR |
| owner_facet | DE-M382 DE-12 DE-19 DE-BY-UBM DE-521 DE-188 DE-355 DE-BY-UBR |
| physical | 41 S. graph. Darst. |
| psigel | ebook |
| publishDate | 2011 |
| publishDateSearch | 2011 |
| publishDateSort | 2011 |
| publisher | CESifo |
| record_format | marc |
| series | CESifo working paper |
| series2 | CESifo working paper |
| spelling | Grossmann, Volker 1971- Verfasser (DE-588)122499263 aut Do cost-sharing and entry deregulation curb pharmaceutical innovation? Volker Grossmann München CESifo 2011 41 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier CESifo working paper 3439 : Category 1, Public finance CESifo working paper 3439 : Category 1, Public finance (DE-604)BV013978326 3439 http://www.cesifo-group.de/portal/pls/portal/docs/1/1205521.PDF kostenfrei Volltext |
| spellingShingle | Grossmann, Volker 1971- Do cost-sharing and entry deregulation curb pharmaceutical innovation? CESifo working paper |
| title | Do cost-sharing and entry deregulation curb pharmaceutical innovation? |
| title_auth | Do cost-sharing and entry deregulation curb pharmaceutical innovation? |
| title_exact_search | Do cost-sharing and entry deregulation curb pharmaceutical innovation? |
| title_full | Do cost-sharing and entry deregulation curb pharmaceutical innovation? Volker Grossmann |
| title_fullStr | Do cost-sharing and entry deregulation curb pharmaceutical innovation? Volker Grossmann |
| title_full_unstemmed | Do cost-sharing and entry deregulation curb pharmaceutical innovation? Volker Grossmann |
| title_short | Do cost-sharing and entry deregulation curb pharmaceutical innovation? |
| title_sort | do cost sharing and entry deregulation curb pharmaceutical innovation |
| url | http://www.cesifo-group.de/portal/pls/portal/docs/1/1205521.PDF |
| volume_link | (DE-604)BV013978326 |
| work_keys_str_mv | AT grossmannvolker docostsharingandentryderegulationcurbpharmaceuticalinnovation |